Armistice Capital’s Salarius Pharmaceuticals SLRX Stock Holding History

Armistice Capital’s Portfolio SLRX Stock Details SLRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$54.1K	Buy
2024 Q1	$44.4K	Sell
2023 Q4	$57.2K	Sell
2023 Q3	$148K	Buy
2023 Q2	$163K	Buy